Product logins

Find logins to all Clarivate products below.


Cardiac Rhythm Management Devices | Market Insights | Europe (Supplemental) | 2024

The European CRM device market will continue to experience modest growth through 2032, primarily due to increasing adoption of premium-priced devices such as leadless pacemakers and S-ICDs. However, revenue growth will be limited to some extent by ASP declines caused by increasing competition in the leadless pacemaker and S-ICD markets.

This Medtech 360 Report provides comprehensive data and analysis on the state of the European CRM device market from 2019 through 2032.

Related Medtech Insights Reports

Report
Biosurgical Agents – Market Insights – Europe
The Europe biosurgical agent market will exhibit modest growth over the forecast period. This expansion will be fueled by a continued preference for biosurgical agents over alternative solutions,…
Report
Trauma Devices – Market Insights – Europe
Although financial constraints among European healthcare facilities and the rise of GPOs that will exert downward pressure on ASPs will limit the European trauma device market, favorable…
Report
Cardiac Rhythm Management Devices – Market Insights – United States
The US CRM device market is expected to grow rapidly through 2034, driven by the increasing adoption of innovative devices, such as dual-chamber leadless pacemakers and extravascular ICDs. These…
Report
Infusion Pumps – Market Insights – Europe
The European infusion pump demand will be underpinned by aging populations and rising chronic disease, while accelerating adoption of closed-loop, EHR-integrated smart pumps and growing demand of…
Report
Laparoscopic Devices – Market Insights – Europe
Laparoscopic procedure volumes in Europe will grow only modestly through 2034, with notable variation across procedure types. Bariatric and colorectal laparoscopic surgeries are expected to…